In today’s briefing:
- Find Out When HMM’s Upcoming Early Redemption Requests Might Drop
- Korea Small Cap Gem #28: Chokwang Leather – A Cheaper Way to Invest in Berkshire Hathaway
- HK Inno.N (195940 KS): 2024 Will See Robust Profit Growth On Growing Momentum of Key Drug
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
Find Out When HMM’s Upcoming Early Redemption Requests Might Drop
- Despite this pattern persisting for years, there has still been a significant price impact each time it surfaces. Therefore, we should pay attention to the upcoming CB conversion schedule.
- A consistent observation is that the price impact is most significant at the announcement of early redemption requests.
- The anticipated announcement dates for the forthcoming early redemption requests are: around May 20th (195th conversion), around September 20th (196th conversion), and around March 20th of next year (197th conversion).
Korea Small Cap Gem #28: Chokwang Leather – A Cheaper Way to Invest in Berkshire Hathaway
- At the end of 2023, Chokwang Leather owned 190.3 billion won worth of Berkshire Hathaway shares, which represents 56% of Chokwang Leather’s market cap.
- Chokwang Leather also has 3.1 million treasury shares (46.6% of outstanding shares). It has the highest levels of treasury shares as a percentage of outstanding shares among Korean stocks.
- Chokwang Leather is likely to be one of the key companies to be targeted to improve its corporate governance as part of the Corporate Value Up program.
HK Inno.N (195940 KS): 2024 Will See Robust Profit Growth On Growing Momentum of Key Drug
- HK inno.N (195940 KS) is expected to see significant improvement in operating profit margin this year to 10.9% (vs. 8% in 2023).
- Growing sales of flagship drug K-CAB, increasing capacity utilization in new IV fluids plant, and improving profitability of health and beauty products segment, will be three important margin drivers.
- With accelerating global presence, HK inno is on track to achieve its target of entering 100 countries by 2028 and achieve global sales of KRW2 trillion ($1.4 billion) by 2030.